Replies to post #216394 on Biotech Values

[jbog]

This PR was issued Friday morning, causing MNTA to break its 12-month high

Not there yet, but hopefully some news can push it there. It was in the $18's and $19's in the Jan/Feb timeframe.

It's been fooling around for 11 months with 40mg Copaxone. Enough is enough.


P.S., When was Wheeler ever right?

[DewDiligence]

This looks like competition for MNTA’s autoimmune program:

https://endpts.com/eyeing-a-multibillion-dollar-market-shire-snags-preclinical-ivig-rival-from-ab-biosciences/